Journal of Managed Care & Specialty Pharmacy’s Post

𝗔𝘀 𝗿𝗲𝗽𝗼𝗿𝘁𝗲𝗱 𝗯𝘆 Reuters, 𝗠𝗲𝗱𝗶𝗰𝗮𝗿𝗲 𝗶𝘀 𝗴𝗶𝘃𝗶𝗻𝗴 𝗱𝗿𝘂𝗴𝗺𝗮𝗸𝗲𝗿𝘀 𝗮 𝗹𝗶𝘁𝘁𝗹𝗲 𝗺𝗼𝗿𝗲 𝗯𝗿𝗲𝗮𝘁𝗵𝗶𝗻𝗴 𝗿𝗼𝗼𝗺 𝗶𝗻 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗿𝗼𝘂𝗻𝗱 𝗼𝗳 𝗽𝗿𝗶𝗰𝗲 𝗻𝗲𝗴𝗼𝘁𝗶𝗮𝘁𝗶𝗼𝗻𝘀. The updated rules allow more time for back-and-forth between pharmaceutical companies and CMS, with earlier meetings and additional opportunities for counter offers. While this round affects the costliest medications and kicks in by 2027, it's clear the government wants to be perceived as pushing hard for lower prices. #Medicare #DrugPrices #Healthcare #CMS #Pharma #CostReduction #HealthPolicy #pharmalobby

With the full implementation of the Inflation Reduction Act, pharmaceutical companies must ready themselves for a more unified Medicare landscape. https://ow.ly/agU050SQmLM MMIT's Meghan Puglisi examines the latest research on payer responses to the IRA. Click the link in this post to read the full article, which offers insights and strategies for staying ahead in this evolving environment. #Pharma #PharmaCompanies #Medicare #IRA #InflationReductionAct

With the full implementation of the Inflation Reduction Act, pharmaceutical companies must ready themselves for a more unified Medicare landscape. https://ow.ly/iEtK50SQmT1 MMIT's Meghan Puglisi examines the latest research on payer responses to the IRA. Click the link in this post to read the full article, which offers insights and strategies for staying ahead in this evolving environment. #Pharma #PharmaCompanies #Medicare #IRA #InflationReductionAct

Your contracts are your bottom line for revenue and this can impact quality care and patient outcomes. Having knowledge of your contracts and negotiating them is a priority, especially in a post-covid environment where employee staffing, inflation, and supply chain costs are a huge impact to most practices. 1) Are you evaluating your contracts every two years or as market demand or pharmaceutical pricing dictates? 2) Reviewing contracts every two years keeps your contracts top of mind and an open communication with the payers. Pharmaceutical pricing, example: If there is a significant change in a drug cost and the provider group is bearing the cost of the drug. Renegotiating is important to stay on top of these costs for a healthy bottom line. For more information: Email: https://lnkd.in/eiMpBnFb Calendly 15 Min Consult: https://lnkd.in/eiMpBnFb

Wondering what Medicare drug price negotiation means for the commercial insurance market? Check out this free webinar for an insightful conversation between John O'Brien and Shawn Gremminger. #employersponsoredinsurance #ira #medicaredrugpricenegotiation

Medicare drug price negotiation refers to the ability of the Medicare program to negotiate directly with pharmaceutical companies to lower the prices of prescription drugs. This policy, which has been introduced as part of broader healthcare reforms, can have several implications for employers who provide health benefits to their employees. So, what does #Medicare drug price negotiation mean for employers? Join us tomorrow as we discuss ➡ https://lnkd.in/eGHKn5-w

Exciting update! Starting in 2024, the annual ceiling for pharmaceutical prices for seniors is dropping to $2000. At DiRx, our mission is twofold: to educate individuals about the pharmaceutical landscape and to offer more accessible medication options for all Americans. Stay informed and empowered with DiRx! 💊🎉 #bigpharma #pharma #healthcare #healthinsurance #prescriptions #genericmedicine #americanhealthcare #dirx #dirxhealth

Check out our latest blog post if you're interested in learning about some of the downstream effects of CMS's Drug Price Negotiation Program. Thanks to Scott Briggs and Matthew Riordan for the partnership on this!

This pharmaceutical monopoly mean that the biggest PBMs can push policies that undermine local pharmacies and raise the cost of lifesaving drugs: NOT what you want in a healthcare partner. We like working with the remaining 21% of PBMs who do transparency pricing and provide rebates to employers regardless of size, saving YOU money! With so many local pharmacies closing , it's more obvious than ever that we need a #HealthInsuranceRevolution where more people partner with PBMs that have your employees best interest at heart! #healthinsurance #healthinsuranceforbusinesses #healthinsuranceconsulting #businessROI #smallbusinesscosts #financeplanning #PBM #Pharmacybenefitmanager #healthinsurancedefinition

Fall ushers in cooler days, but Americans aren't getting the same relief from the heat of rising medication prices. The causes behind this trend are complex and often misunderstood by many. Our latest deep dive examines how key industry players influence the costs consumers see at the pharmacy counter. Explore the various aspects of the pharmaceutical pricing system, including rebates and formulary decisions. Click the link to learn more about the major factors affecting #drugpricing. 🔗 https://lnkd.in/g-vzrY2h #prescriptiondrugs #healthcarereform #pbm #SmithRx